Breast Neoplasms: all 12,828 studies
Page 72 of 129. Open to participants first (2,932), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast CancerCompletedNCT04408560Not applicable
- First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBCCompletedNCT04408118Phase 2
- Pyrotinib in Combination With Letrozole in Patients With HER2-Positive, ER-Positive Metastatic Breast CancerStatus unknownNCT04407988Phase 2
- The Frequency of Thyroid Diseases in Women With Breast CancerCompletedNCT04406779
- A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC)Status unknownNCT04405505Phase 3
- Investigation of Genomic Alteration in Patients With Luminal A or Luminal B SubtypesActive, not recruitingNCT04403984
- Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast CancerStatus unknownNCT04403529Phase 3
- Perioperative Oral Nutrition Supplementation in Malnourished Surgical Cancer PatientsCompletedNCT04400552Not applicable
- Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast CancerActive, not recruitingNCT04398914Phase 2
- A Study to Evaluate the Pharmacokinetics of Margetuximab in Chinese Patients With HER2+ MBCCompletedNCT04398108Phase 1
- An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC.Active, not recruitingNCT04395989Phase 2
- An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 PandemicApproved for marketingNCT04395508
- GM1 Prophylaxis for WBRT Related Cognitive DysfunctionTerminatedNCT04395339Phase 3
- Digi-Do - a Digital Information Tool to Help Patients Diagnosed With Breast CancerCompletedNCT04394325Not applicable
- Relationship Between Body Composition, Food Consumption, and Micro and Macronutrients With Gene Expression in Breast CancerStatus unknownNCT04389424
- Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic VinorelbineStatus unknownNCT04389073Phase 2
- Real-life Pan-HER-blockade With NeratinibCompletedNCT04388384
- Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.Status unknownNCT04387630Phase 2/3
- Health Economy RegisterCompletedNCT04386629
- A Comparative Study of Pravastatin vs Placebo as Primary Prevention of Severe Subcutaneous Breast Fibrosis in Hyper-radiosensitive Identified Patients With Breast CancerTerminatedNCT04385433Phase 3
- Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS)Active, not recruitingNCT04383275Phase 2
- B002 in Patients With HER2-positive Breast CancerCompletedNCT04382352Phase 1
- Healthy Lifestyles and Quality of Life in Women With Breast CancerCompletedNCT04379908
- YES Study - Newly Diagnosed/Metastatic InterventionActive, not recruitingNCT04379414Not applicable
- Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal SymptomsTerminatedNCT04379024Early Phase 1
- A Patient-centered Continuous and Interdisciplinary Shared Decision Making Approach for Breast Cancer RehabilitationStatus unknownNCT04378816Not applicable
- Optimizing Quality of Life in Women Living With Metastatic Breast CancerCompletedNCT04374825Not applicable
- Fruit and Vegetable Intervention in Lactating Women to Reduce Breast Cancer RiskStatus unknownNCT04374747Not applicable
- Online Psychosocial Cancer Screening, Monitoring and Stepped Treatment in Cancer SurvivorsCompletedNCT04372459Not applicable
- Characterization of Innate Immune System in Patients With Luminal Advanced Breast CancerTerminatedNCT04370522
- Modifications of Immune Microenvironment Induced by Neoadjuvant Chemotherapy in Triple-negative BCCompletedNCT04368468
- Cohort Study of Patients With HER2-negative MBC and BRCA 1/2 Pathogenic MutationStatus unknownNCT04368442
- Pharmacokinetic Study of Pyrotinib and Docetaxel in Combination With Trastuzumab in Patients With HER2 Metastatic Breast CancerCompletedNCT04367090Phase 1
- Histology VABB-Histology Post Surgery Pilot Project (BETTY Trial)Active, not recruitingNCT04365803
- Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer AdenocarcinomaActive, not recruitingNCT04365790
- Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling ProgramCompletedNCT04365569Not applicable
- Molecular Neuroimaging to Assess the Link Between Neuroinflammation and Cognitive Impairment in Breast CancerWithdrawnNCT04364672Phase 1
- Chemotherapy-induced Circadian Rhythm DisruptionStatus unknownNCT04364347
- Molecular Profiling After Neoadjuvant Chemotherapy for Triple-negative Breast CancerStatus unknownNCT04362462
- Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion StudyCompletedNCT04361240
- PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast CancerActive, not recruitingNCT04360941Phase 1
- The Diagnosis and Prognosis of Nonpalpable Breast Cancer Detected by the US vs Mammography: a Clinical Noninferiority Trial.Status unknownNCT04360616
- What Are the Benefits and Harms of Risk Stratified Screening in the NHS Breast Screening Programme: Study ProtocolCompletedNCT04359420Not applicable
- Contraception and Cervical and Breast Cancer Screening in Obese Versus Non-obese WomenCompletedNCT04357652
- Molecularly Targeted Umbrella Study in Luminal Advanced Breast CancerStatus unknownNCT04355858Phase 2
- A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast CancerStatus unknownNCT04355520Phase 1/2
- Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast CancerCompletedNCT04354675Not applicable
- A Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Metastatic Breast CancerCompletedNCT04354233Not applicable
- Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast CancerCompletedNCT04352777Phase 2
- Culturally Appropriate Nutrition Communication for Mexican American WomenCompletedNCT04352530Not applicable
- T-DM1 With or Without Abemaciclib for the Treatment of HER2-Positive Metastatic Breast CancerWithdrawnNCT04351230Phase 2
- Impact of the COVID-19 Pandemic in Gynecological OncologyCompletedNCT04351139
- Rehabilitation Through Hippotherapy for the Management of Women After Primary Treatment of Breast CancerCompletedNCT04350398Not applicable
- Endocrinological Changes Due to Pre-medications of Chemotherapy in Patients With Breast CancerCompletedNCT04350229Not applicable
- Effect of Low Dose Metronomic Chemotherapy in Metastatic Breast CancerCompletedNCT04350021
- Interest of Touch-massage in Hospital Day CareCompletedNCT04348955
- Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid TumorsTerminatedNCT04348916Phase 1
- Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ CancerWithdrawnNCT04348643Phase 1/2
- Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening MammographyCompletedNCT04348123Not applicable
- SMS Messaging as a Tool to Improve Cancer Screening ProgramsCompletedNCT04343950Not applicable
- Delayed Breast Reconstruction by Prepectoral Implant After Lipo-preparation (RM2prepec)CompletedNCT04343820
- Effectiveness of Ultrasound Guided PECS Block on Opioid Consumption and Patient Satisfaction Through Adequate Pain Control Following Breast Cancer Surgery.CompletedNCT04343807Not applicable
- Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)CompletedNCT04341129Early Phase 1
- Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose ReductionCompletedNCT04340180Phase 1
- Postoperative Identification of Tumor Cells At the Lumpectomy Site of Patients with Early Breast CancerSuspendedNCT04339517Not applicable
- Effects of Physical Exercise on Cardio-vascular Efficiency and Quality of Life in Breast Cancer SurvivorsCompletedNCT04337736Not applicable
- Ultrasound Guided Rhomboid Intercostal and Subserratus Plane Block in Breast Cancer SurgeriesCompletedNCT04336917Phase 4
- Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid TumorsActive, not recruitingNCT04336241Phase 1
- NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBCActive, not recruitingNCT04335669Phase 3
- A Phase 3 Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib, Carelizumab Plus Nab-paclitaxel, and Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer.TerminatedNCT04335006Phase 3
- Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in ChinaStatus unknownNCT04334330Phase 2
- Long-term Improvement of Quality of Life in Breast Cancer Patients With Quality of Life Diagnosis and TherapyCompletedNCT04334096Not applicable
- To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast CancerWithdrawnNCT04332549Phase 1
- The Genomic Medicine at VA StudyActive, not recruitingNCT04331535Not applicable
- Prolonged Nightly Fasting in Breast Cancer SurvivorsCompletedNCT04330339Not applicable
- Satisfaction and QUality of Life After Breast REconstructionCompletedNCT04329819
- To Assess the Efficacy of the LYMPHA in the Prevention of Lymphedema Following Axillary Dissection for Breast CancerStatus unknownNCT04328610Not applicable
- Autotaxin (ATX) as a Marker for Breast CancerStatus unknownNCT04328194Not applicable
- MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer SurgeryCompletedNCT04327063Phase 3
- SCOPE-Chinese Women StudyCompletedNCT04326660Not applicable
- Avanzando Juntas: Adapting an Evidence Based Weight Loss Program for Hispanic Breast Cancer SurvivorsCompletedNCT04321135Not applicable
- Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer PatientsActive, not recruitingNCT04320979Phase 3
- Expanded Access for IMMU-132Approved for marketingNCT04320693
- [18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast CancersCompletedNCT04320030Phase 2
- Supportive Effects of Craniosacral Therapy for Women With Breast CancerCompletedNCT04319510Not applicable
- Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal TherapyStatus unknownNCT04318223Phase 2
- Demographic , Clinicopathological Characteristics and Survival of Breast CancerStatus unknownNCT04316247
- Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast CancerWithdrawnNCT04316169Phase 1
- Real-time Interactive Digital Healthcare System in Patients With Breast Cancer; Randomized Controlled TrialCompletedNCT04316156Not applicable
- Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE StudyActive, not recruitingNCT04316117Phase 2
- Training With Mobile Application in Breast CancerCompletedNCT04315012Not applicable
- Tamoxifen Dose Adjustment on Indonesian Female ER+ Breast Cancer Patients Based on CYP2D6 Genotype and Endoxifen LevelsCompletedNCT04312347Not applicable
- Circulating Tumor DNA and Immunophenotyping as Potential Biomarkers With Regional Nodal Irradiation for Breast CancerActive, not recruitingNCT04308720
- Exercise in Breast Cancer SurvivorsCompletedNCT04307407Not applicable
- Monalizumab and Trastuzumab In Metastatic HER2-pOSitive breAst Cancer: MIMOSA-trialCompletedNCT04307329Phase 2
- NX in Luminal B Breast Cancer Patients After Neoadjuvant ChemotherapyStatus unknownNCT04307147Phase 3
- ERAS in Autologous Breast Reconstruction: A Pilot RCTCompletedNCT04306003Not applicable
- Risk Reduction Program for Women Having High Risk of Breast CancerCompletedNCT04304404Not applicable
- A Phase II Study of Triple-negative Breast Cancer Brain Metastases.Status unknownNCT04303988Phase 2
- A Phase II Trial of Camrelizumab in Combination With Apatinib and Eribulin in Patients With Advanced TNBCStatus unknownNCT04303741Phase 2